Is tonsillectomy indicated for acute tonsillitis?

Tonsillectomy for Acute Tonsillitis

Tonsillectomy is NOT indicated for a single episode of acute tonsillitis—this is a viral or bacterial infection that should be managed conservatively with symptomatic treatment and, when appropriate, antibiotics for confirmed group A streptococcal infection. 1

Key Distinction: Acute vs. Recurrent Tonsillitis

The critical error in clinical practice is confusing acute tonsillitis (a single episode) with recurrent acute tonsillitis (multiple documented episodes over time). Surgery is never appropriate for isolated acute infections.

For Acute Tonsillitis (Single Episode):

• Symptomatic treatment: Paracetamol and/or NSAIDs for pain and fever 2
• Antibiotic therapy: Only when bacterial infection (particularly group A beta-hemolytic streptococcus) is confirmed or highly suspected using validated scoring systems (Centor, McIsaac, FeverPain) or point-of-care testing 1, 2
• Watchful waiting: Most cases resolve spontaneously 1

When Tonsillectomy IS Indicated: The Paradise Criteria

Tonsillectomy may be recommended ONLY when recurrent throat infections meet specific frequency thresholds with proper documentation 1:

Frequency Requirements (ALL must be documented):

• ≥7 episodes in the past year, OR
• ≥5 episodes per year for 2 consecutive years, OR
• ≥3 episodes per year for 3 consecutive years

Required Documentation for EACH Episode:

Each episode must be documented in the medical record with:

• Sore throat PLUS at least ONE of the following:
  • Temperature >38.3°C (>101°F)
  • Cervical lymphadenopathy (tender or >2 cm)
  • Tonsillar exudate
  • Positive test for group A beta-hemolytic streptococcus

1

Clinical Reality: Modest Benefits

Even when criteria are met, the benefit of tonsillectomy is modest. In the first postoperative year, children undergoing surgery experience approximately 0.6 fewer episodes of sore throat compared to conservative management (3.0 vs 3.6 episodes), and one of those three episodes in the surgical group is the predictable postoperative pain lasting 5-7 days 3. For severely affected children, the reduction in moderate/severe episodes is only 0.1 episodes (1.1 vs 1.2), though this excludes the immediate postoperative episode 3.

Important Caveats:

• Spontaneous improvement is common: Many patients in non-surgical groups improve without intervention 1, 3
• Surgery prevents "tonsillitis" but not all "sore throats": The impact on pharyngitis from other causes is unpredictable 3
• Surgical risks: Primary and secondary hemorrhage (19% bleeding rate in adults), dehydration, and anesthetic complications must be weighed against modest benefits 4, 3

Modifying Factors That May Lower the Threshold

For patients NOT meeting Paradise criteria, consider tonsillectomy if they have 1:

• Multiple antibiotic allergies/intolerance
• PFAPA syndrome (periodic fever, aphthous stomatitis, pharyngitis, adenitis)
• History of >1 peritonsillar abscess

Adult Considerations

In adults with recurrent acute tonsillitis meeting criteria, tonsillectomy reduces sore throat episodes by 3.6 episodes over 6 months and decreases sore throat days by 10.6 days, though postoperative pain lasts 13-17 days 4. Recent evidence suggests current guidelines may be too restrictive, as even adults not meeting strict criteria show sustained quality-of-life improvements at 12-36 months post-surgery 5, 6.

Shared Decision-Making Algorithm

1. Document frequency and features of each episode meticulously
2. Calculate if Paradise criteria are met using the specific thresholds
3. Assess modifying factors if criteria not met
4. Discuss the modest benefits: ~0.6 fewer episodes/year, with one being predictable postoperative pain
5. Explain risks: Bleeding (19%), pain lasting 1-2 weeks, rare severe complications
6. Consider quality of life impact using validated tools like TOI-14 (preoperative score is the strongest predictor of benefit) 5, 6

The 2019 AAO-HNS guideline provides a STRONG recommendation for watchful waiting when frequency criteria are NOT met 1, emphasizing that surgery should be reserved for carefully selected, well-documented cases where the modest benefits outweigh real surgical risks.